ACADIA Pharmaceuticals shares are trading lower. The company reported Q2 financial results. Morgan Stanley downgraded the stock to Equal-Weight following the report.
Portfolio Pulse from Benzinga Newsdesk
ACADIA Pharmaceuticals shares are trading lower after the company reported Q2 financial results. Morgan Stanley downgraded the stock to Equal-Weight following the report.
August 07, 2024 | 11:44 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ACADIA Pharmaceuticals shares are trading lower after the company reported Q2 financial results. Morgan Stanley downgraded the stock to Equal-Weight following the report.
The combination of disappointing Q2 financial results and a downgrade from Morgan Stanley to Equal-Weight is likely to negatively impact ACADIA Pharmaceuticals' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100